You are here

  • Home
  • Archive
  • Volume 70, Issue 5
  • Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Article Text

Article menu
Download PDFPDF
Letters
Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

https://doi.org/10.1136/ard.2010.136093

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding Funding of the Dutch affiliations of Wyeth Pharmaceuticals, Abbott Pharmaceuticals, Schering-Plough Corporation, Roche Pharmaceuticals, UCB Pharma and Bristol-Myers Squibb enabled the data collection for the DREAM cohort.

    • Competing interests The DREAM registry is funded by several pharmaceutical industries including Roche Pharmaceuticals.

    • Ethics approval The protocol of the DREAM registry has been approved by the responsible medical ethical committee.

    • Provenance and peer review Not commissioned; externally peer reviewed.